NCT05842031

Brief Summary

To learn more about the patient experience undergoing inguinal (in the groin) lymph node procedures for penile cancer during and after surgery.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
8mo left

Started Apr 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Apr 2023Dec 2026

Study Start

First participant enrolled

April 14, 2023

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

April 24, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

3.7 years

First QC Date

April 24, 2023

Last Update Submit

March 2, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Decision Regret Scale (DRS) questionnaires

    Score Scale ranges (1-5) 1. Strongly Agree 2. Agree 3. Agree nor Disagree 4. Disagree 5. Strongly Disagree

    through study completion; an average of 1 year

Study Arms (1)

Semi-structured interviews

Participants with penile cancer who have undergone invasive inguinal lymph node procedure will be recruited to participate in study via telephone recruitment.

Behavioral: Quality of Life QuestionnairesBehavioral: Patient Educational NeedsBehavioral: Symptom Management

Interventions

Identify what interventions may be helpful in improving quality of life.

Semi-structured interviews

Identify what interventions may be helpful in improving patient educational needs

Semi-structured interviews

Identify what interventions may be helpful in improving symptom management Improve symptom management

Semi-structured interviews

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

M D Anderson Cancer Center

You may qualify if:

  • Patients diagnosed with penile cancer who have undergone invasive inguinal node procedures (ILND and/or DSNB) and are at least 6 months post-procedure

You may not qualify if:

  • Patient's ≤18 years of age
  • Patients who have not undergone invasive surgical procedures involving the inguinal lymph nodes
  • Non-English-speaking patients For interviews: people who are physically and/or cognitively incapable of participating in a 60minute telephone interview as determined by a clinical provider or the patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Penile Neoplasms

Interventions

Palliative Care

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesPenile DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Curtis Pettaway, BS, MD

    MD Anderson

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2023

First Posted

May 3, 2023

Study Start

April 14, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 4, 2026

Record last verified: 2026-03

Locations